Company / Operating Margin
KYNTRA BIO, INC. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-507.8%
FY2025
5-year range
-689.5% / -34.8%
FY2021-FY2025
Trend
+26.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 3 years of decline, reaching -507.8%.
Based on SEC 10-K filings.
-507.8% in FY2025 with a 5-year CAGR of -467.1%.
Declined from -122.6% to -507.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -399.0pp
- 5-Year Change
- -467.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 26.4% year-over-year.
- Peak operating margin was recorded in FY2018.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -507.8% | +26.4% |
| FY2024 | -689.5% | -462.3% |
| FY2023 | -122.6% | -12.7% |
| FY2022 | -108.8% | -212.6% |
| FY2021 | -34.8% | +14.5% |
| FY2020 | -40.7% | +54.5% |
| FY2019 | -89.5% | -227.7% |
| FY2018 | -27.3% | +36.4% |
| FY2017 | -42.9% | -17.9% |
| FY2016 | -36.4% | -368.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026